Showing results (271-280 of 9,661) with videos related to
Sort By:
Pageof 967
Leukemia|October 12, 2011
Inhibition of Myb-dependent gene expression by the sesquiterpene lactone mexicanin-IT Bujnicki, C Wilczek, C Schomburg, et al.Leukemia|September 20, 2011
Significantly worse survival of patients with NIH-defined chronic graft-versus-host disease and thrombocytopenia or progressive onset type: results of a prospective studyZ Kuzmina, S Eder, A Böhm, et al.Leukemia|December 23, 2011
BCL2 mutations in diffuse large B-cell lymphomaJ M Schuetz, N A Johnson, R D Morin, et al.Leukemia|May 29, 2009
Class effects of tyrosine kinase inhibitors in the treatment of chronic myeloid leukemiaF J Giles, M O'Dwyer, R SwordsLeukemia|June 12, 2009
Heritable T-cell malignancy models established in a zebrafish phenotypic screenJ K Frazer, N D Meeker, L Rudner, et al.Leukemia|December 21, 2011
Pivotal role of paracrine effects in stem cell therapies in regenerative medicine: can we translate stem cell-secreted paracrine factors and microvesicles into better therapeutic strategies?M Z Ratajczak, M Kucia, T Jadczyk, et al.Leukemia|December 21, 2011
Src inhibitors, PP2 and dasatinib, increase retinoic acid-induced association of Lyn and c-Raf (S259) and enhance MAPK-dependent differentiation of myeloid leukemia cellsJ Congleton, R MacDonald, A YenLeukemia|December 21, 2011
Inhibition of CXCR4 in CML cells disrupts their interaction with the bone marrow microenvironment and sensitizes them to nilotinibE Weisberg, A K Azab, P W Manley, et al.Leukemia|February 25, 2012
Selective, novel spleen tyrosine kinase (Syk) inhibitors suppress chronic lymphocytic leukemia B-cell activation and migrationJ Hoellenriegel, G P Coffey, U Sinha, et al.Leukemia|March 1, 2012
Treatment of acute lymphoblastic leukemia with an rGel/BLyS fusion toxinR Parameswaran, M Yu, M-A Lyu, et al.Pageof 967